Adaptive Biotechnologies Corporation
NASDAQ:ADPT
Overview | Financials
Company Name | Adaptive Biotechnologies Corporation |
Symbol | ADPT |
Currency | USD |
Price | 7.37 |
Market Cap | 1,087,657,230 |
Dividend Yield | 0% |
52-week-range | 2.28 - 8.33 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Chad M. Robins M.B.A, M.B.A. |
Website | https://www.adaptivebiotech.com |
An error occurred while fetching data.
About Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD